Discover investment opportunities in Medical AI Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Medical AI Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Medical AI Stocks using our Smart AI Filter.
9 stocks found for "Medical AI Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.50 | ±64.8% | -8.0 | 0.00% | |||
1.02 | ±54.4% | 38.7 | 0.03% | |||
1.24 | ±27.6% | 13.6 | 0.00% | |||
1.02 | ±49.1% | 40.9 | 0.00% | |||
0.36 | ±21.7% | 15.1 | 3.17% | |||
0.64 | ±28.2% | 69.3 | 0.00% | |||
1.00 | ±57.1% | 11.5 | 0.00% | |||
1.06 | ±40.4% | 66.4 | 0.00% | |||
1.77 | ±71.4% | -18.6 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What competitive advantages does Intuitive Surgical (ISRG) have in the medical AI sector?
A: Intuitive Surgical (ISRG) holds a leadership position in robotic-assisted surgery, providing proprietary AI-driven platforms. Its large installed base, extensive patent portfolio, and continuous innovation in AI technology support its competitive edge in minimally invasive surgeries.
Q: How has the historical performance of Guardant Health (GH) stocks been during economic downturns?
A: Guardant Health (GH), focused on oncology diagnostics, typically shows resilience due to the healthcare sector's defensive nature. However, its growth-oriented profile and broader market sentiment can still lead to stock volatility during downturns.
Q: Does Recursion Pharmaceuticals (RXRX) offer significant growth potential in the AI-driven drug discovery space?
A: Recursion Pharmaceuticals (RXRX) leverages AI for faster drug discovery, leading to potential rapid growth. The scalability of its platform may attract investors looking for innovation-driven returns, although clinical success remains crucial.
Q: How do Telehealth companies like Teladoc Health (TDOC) fare in terms of dividend income?
A: Teladoc Health (TDOC) typically does not focus on dividend payments, as it reinvests profits into growth ventures. Investors interested in income may need to consider other companies offering consistent dividends.
Q: What are the main risks of investing in Invitae Corporation (NVTA) within the medical AI sector?
A: Invitae Corporation (NVTA) faces risks from high R&D expenses, competitive pressure in genetic testing, and potential regulatory changes affecting its advanced diagnostic technologies.
Q: What sector-specific opportunities does Repligen Corporation (RGEN) present in the biotech landscape?
A: Repligen Corporation (RGEN) offers products enhancing bioprocessing efficiency, aligning well with biotech expansion strategies. Its innovative solutions may drive operational efficiencies for biopharma companies, leading to sector-specific growth opportunities.